This article has been cited by
1The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions
Mauro Bavetta,Dionisio Silvaggio,Elena Campione,Pietro Sollena,Vincenzo Formica,Deborah Coletta,Grazia Graziani,Maria Concetta Pucci Romano,Mario Roselli,Ketty Peris,Luca Bianchi
Journal of Clinical Medicine.2021;10(3)466
[DOI]
2Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial
G. Brandon Gunn,Tito R. Mendoza,Adam S. Garden,Xin Shelley Wang,Qiuling Shi,William H. Morrison,Steven J. Frank,Jack Phan,Clifton D. Fuller,Mark S. Chambers,Ehab Y. Hanna,Charles Lu,David I. Rosenthal,Charles S. Cleeland
Supportive Care in Cancer.2020;28(1)261
[DOI]
3Nursing Management of Cutaneous Toxicities From Epidermal Growth Factor Receptor Inhibitors
Martin Wallner,Sabine Kck-Hdi,Shaina Booze,Kathryn White,Hanna Mayer
Clinical Journal of Oncology Nursing.2016;20(5)529
[DOI]
4Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial
Xin Shelley Wang,Qiuling Shi,Tito Mendoza,Steven Lin,Joe Y. Chang,Raza H. Bokhari,Hui-Kai Lin,Araceli Garcia-Gonzalez,Mona Kamal,Charles S. Cleeland,Zhongxing Liao
International Journal of Radiation Oncology*Biology*Physics.2020;106(1)100
[DOI]
  Feedback 
  Subscribe